Simplifying HIV Treatment in the Presence of Drug Resistance; Preventing from the Start - Episode 5
Importance of Starting HIV Treatment Early
The panel discusses the importance of starting HIV treatment early after diagnosis and offers advice to clinical providers.
BIC = bictegravir
DRV = darunavir
DTG = dolutegravir
F/TAF = FTC/TAF = Emtricitabine/Tenofovir alafenamide
F/TDF = FTC/TDF = Emtricitabine/Tenofovir disoproxil fumarate
B/F/TAF = BIC/FTC/TAF = Bictegravir/Emtricitabine/Tenofovir alafenamide (single tablet regimen)
DTG/ABC/3TC = Dolutegravir/Abacavir/Lamivudine (single tablet regimen)
DTG + F/TAF = DTG + FTC/TAF = Dolutegravir + Emtricitabine/Tenofovir alafenamide (multi-tablet regimen)
D/C/F/TAF = DRV/COBI/FTC/TAF = Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (single tablet regimen)
DTG/3TC = Dolutegravir/Lamivudine (single tablet regimen)
CAB = Cabotegravir
CAB + RPV = Cabotegravir + Rilpivirine
Video content above is prompted by the following question:
1. Can you emphasize the importance of starting HIV treatment early after diagnosis?
- How do you go about educating your patient on initiating treatment and set them up for long term success?
- Do you start treatment the same day as the patient gets diagnosed? (Preferred regiments for rapid start?)
- Undetectable=untransmissible
- How do you identify barriers that may affect your patients’ treatment goals?
